I thought there was interesting/useful information in this article.
"Lessons Learned from Post-Marketing Experience with PML-Associated Natalizumab" Neurology Today: 20 May 2010 - Volume 10 - Issue 10 - p 17–18
http://journals.lww.com/neurotodayon...rience.13.aspx